论文部分内容阅读
目的观察尼莫地平对慢性脑供血不足患者的临床效果。方法择取本院2014年7月至2016年7月期间收治的90例慢性脑供血不足患者作为本次研究对象,采取随机分组法将患者分成2组,各45例。对照组采取常规治疗方案。观察组在常规治疗的基础上给予患者尼莫地平治疗。比较2组患者治疗前后各动脉的血流速率和眩晕症状评分。结果 2组患者治疗前的各动脉血流速率、眩晕症状评分对比无统计学意义,观察组患者治疗后各动脉血流速率大于对照组,眩晕症状评分比对照组低(P<0.05)。结论尼莫地平是治疗慢性脑供血不足的有效药物。
Objective To observe the clinical effect of nimodipine on patients with chronic cerebral insufficiency. Methods Totally 90 patients with chronic cerebral insufficiency admitted from July 2014 to July 2016 in our hospital were selected as the study subjects. Patients were divided into two groups (n = 45) randomly. The control group to take conventional treatment. The observation group was treated with nimodipine on the basis of routine treatment. The blood flow rate and dizziness symptom score of each artery in two groups before and after treatment were compared. Results There was no significant difference in the arterial blood flow rate and vertigo symptom before treatment in two groups. The blood flow velocity of each artery in the observation group was higher than that in the control group after treatment, and the vertigo symptom score was lower than the control group (P <0.05). Conclusion Nimodipine is an effective drug for treating chronic cerebral insufficiency.